Antisense oligonucleotides, and particularly those with phosphorothioate ba
ckbones, have emerged as potential gene specific therapeutic agents and are
currently undergoing evaluation in clinical trials for a variety of diseas
es. In the area of HIV-I therapeutics, targeting of oligonucleotides to inf
ected cells, such as macrophages, would be highly desirable. The present st
udy was designed to prepare and characterize oligonucleotide-loaded nanopar
ticles for this purpose. Due to their hydrophilic characteristics, oligonuc
leotides are difficult to entrap in polymeric particles. Here, the oligonuc
leotides were first complexed with cetyltrimethylammonium bromide. The olig
onucleotide-loaded nanoparticles were prepared by the emulsification-diffus
ion method and subsequently purified. In comparison with previous studies,
a high oligonucleotide-loading was achieved: 2.5, 5 and 10% oligonucleotide
loading were assessed. If the initial oligonucleotide content was 4%, this
method produced a final oligonucleotide loading of 1.9% with an entrapment
efficiency of 47%. The integrity of the oligonucleotide and of the polymer
, in the final freeze-dried product, was retained. (C) 1999 Elsevier Scienc
e B.V. All rights reserved.